No Data
No Data
No Data
No Data
No Data
Is Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Yahoo FinanceApr 18 07:57
Malibu Shines a Light on CLINUVEL's Pioneering Work in Photomedicine
Yahoo FinanceMar 5 10:38
Clinuvel Pharmaceuticals GAAP EPS of A$0.22, Revenue of A$32.25B
Seeking AlphaFeb 23 23:16
Earnings Call Summary | CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV(CLVLY.US) Q2 2023 Earnings Conference
The following is a summary of the Clinuvel Pharmaceuticals Limited (CLVLY) Q2 2023 Earnings Call Transcript:Financial Performance:Clinuvel Pharmaceuticals reported a 15% increase in total revenue and
Futu NewsFeb 23 20:09 · Conference Call
CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV To Go Ex-Dividend On September 7th, 2023 With 0.03211 USD Dividend Per Share
August 31st - $CLINUVEL PHARMACEUTICALS LTD SPON ADR EA REP 1 ORD NPV(CLVLY.US)$ is trading ex-dividend on September 7th, 2023. Shareholders of record on September 8th, 2023 will receive 0.03211 U
Futu NewsAug 31, 2023 07:40
Clinuvel Pharmaceuticals reports 1H results
Clinuvel Pharmaceuticals (OTCPK:CLVLY) press release: 1H GAAP EPS of A$11.90c.Revenue of A$24.63M (+56.5% Y/Y).
Seeking AlphaFeb 23, 2022 22:24
No Data
No Data